SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-18-000293
Filing Date
2018-01-09
Accepted
2018-01-09 06:36:07
Documents
1
Period of Report
2018-01-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-40683.html 4  
1 PRIMARY DOCUMENT marketforms-40683.xml 4 3971
  Complete submission text file 0001214659-18-000293.txt   5322
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Issuer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 25801 INDUSTRIAL BLVD., SUITE B HAYWARD CA 94545
Business Address
LIU MAY (Reporting) CIK: 0001577302 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34637 | Film No.: 18517827